Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40.

Wenthe, Jessica; Naseri, Sedigheh; Hellström, Ann-Charlotte; Wiklund, Helena Jernberg; Eriksson, Emma; Loskog, Angelica

Wenthe, Jessica; Naseri, Sedigheh; Hellström, Ann-Charlotte; Wiklund, Helena Jernberg; Eriksson, Emma; Loskog, Angelica.

Afiliação

Wenthe J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. jessica.wenthe@igp.uu.se.
Naseri S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Hellström AC; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Wiklund HJ; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Eriksson E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Loskog A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Cancer Gene Ther ; 27(12): 948-959, 2020 12.

Article em En | MEDLINE | ID: mdl-32355275

Assuntos

Ligante de CD40/metabolismo; Imunoterapia/métodos; Mieloma Múltiplo/genética; Terapia Viral Oncolítica/métodos; Vírus Oncolíticos/genética; Animais; Humanos; Camundongos; Camundongos Nus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ligante de CD40 / Vírus Oncolíticos / Terapia Viral Oncolítica / Imunoterapia / Mieloma Múltiplo Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google